Corneal Cross-Linking with Penetrating Keratoplasty (PKP)
What This Combined Treatment Involves
Understanding how CXL and PKP work together helps patients feel confident going into treatment. Each procedure serves a distinct purpose, and when performed together, they address both the structural and functional needs of a severely diseased cornea.
Penetrating keratoplasty is a surgical procedure that replaces the full thickness of a diseased or damaged cornea with healthy donor tissue. It is recommended when the cornea is so severely scarred, thinned, or irregularly shaped that vision can no longer be restored with non-surgical options. The donor tissue is carefully stitched into place, and the eye gradually integrates the new graft over several months.
Corneal cross-linking uses riboflavin (a form of vitamin B2) drops combined with controlled ultraviolet (UV) light to create new chemical bonds between the collagen fibers in corneal tissue. This process stiffens and strengthens the cornea at a structural level. When applied alongside or following PKP, cross-linking works to stabilize the donor graft, reduce the risk of the graft thinning or bulging over time, and support long-term visual stability.
Performing CXL together with PKP addresses two problems at once. The transplant replaces tissue that is too damaged to function, while cross-linking fortifies the new graft against the same forces that caused the original cornea to fail. Research has shown that this combined approach reduces the likelihood of needing a repeat transplant and improves how long the graft remains healthy and clear.
This combined treatment is used for advanced keratoconus (a condition where the cornea progressively thins and bulges forward), corneal melting caused by autoimmune disease or chemical injury, resistant infectious keratitis (serious corneal infections that have not responded to medication), and corneal scarring from prior disease or surgery. Our Cornea Specialists evaluate each patient individually to determine when this combination offers the best long-term outcome.
Who Is a Candidate for This Treatment?
Not every patient with corneal disease needs a transplant combined with cross-linking. This combined approach is generally reserved for cases where the cornea has reached a stage that cannot be adequately managed through glasses, contact lenses, or less invasive procedures alone.
Keratoconus is a progressive condition in which the cornea gradually thins and takes on an irregular cone-like shape. In early to moderate stages, specialty contact lenses, including rigid gas-permeable (RGP) or scleral lenses, can rehabilitate vision effectively. Cross-linking alone may be appropriate to halt progression in cases where adequate corneal thickness remains. However, when keratoconus has advanced to the point where contact lenses no longer provide functional vision, and significant scarring is present, PKP combined with CXL becomes the more appropriate path.
Fungal and bacterial infections can cause the cornea to deteriorate rapidly. When antimicrobial therapy fails to control the infection, removing the affected tissue through PKP becomes necessary. Adding cross-linking to this procedure supports the new tissue and may help prevent further breakdown or recurrent weakening.
Certain autoimmune conditions, chemical burns, and complications from prior corneal surgeries can cause the cornea to progressively thin and dissolve, a process called corneal melting (or keratolysis). The combined procedure stabilizes the corneal structure, reduces enzymatic breakdown of collagen, and helps preserve both vision and the integrity of the eye itself.
Our Cornea Specialists conduct a thorough pre-surgical evaluation that includes advanced corneal imaging, measurements of corneal thickness, and a full assessment of your ocular health. This individualized planning determines the optimal timing and technique for your specific situation. No two cases are identical, and your care plan is built around you.
How the Procedure Is Performed
The combined surgery is typically performed as an outpatient procedure and generally takes one to two hours, depending on the complexity of the case. Each step is carefully coordinated to prioritize safety and maximize the outcome for the graft.
In the weeks before surgery, your Cornea Specialist will complete comprehensive diagnostic testing, including corneal topography (detailed mapping of the corneal surface) and anterior segment imaging. You may be asked to pause certain medications and will likely begin using antibiotic or anti-inflammatory eye drops ahead of the procedure. Anesthesia options will be discussed during your pre-operative visit.
The surgeon begins by carefully removing the full thickness of the damaged cornea. A precisely matched donor corneal graft is then positioned and secured with fine sutures. Once the graft is in place, riboflavin drops are applied to soak the donor tissue, and controlled UV light is then delivered to activate the cross-linking process, bonding the collagen fibers and strengthening the graft from within.
The procedure is typically performed using local anesthesia to numb the eye, with sedation available to help you remain comfortable and relaxed throughout. Post-operative discomfort is generally mild and manageable with over-the-counter pain relief and your prescribed eye drop regimen.
A protective shield is placed over your eye before you leave the surgical suite. You will begin a course of antibiotic and anti-inflammatory eye drops to prevent infection and control swelling. Some light sensitivity, a scratchy sensation, or mild blurring of vision in the first days is expected and normal. Most patients go home the same day.
Benefits and Potential Risks
As with any surgical procedure, combining CXL with PKP carries both meaningful benefits and potential risks. Understanding both helps you make an informed decision alongside your Cornea Specialist.
The primary goal of this procedure is to restore functional vision by replacing a cornea that can no longer perform its role. The addition of cross-linking enhances graft stability, reduces the risk of corneal melting in the donor tissue, and lowers the likelihood of needing a future repeat transplant. For many patients, this translates to years of improved clarity and corneal health that would not have been achievable with transplantation alone.
Potential risks associated with this procedure include infection, graft rejection (where the immune system responds to donor tissue), persistent swelling, delayed healing, or increased astigmatism (irregular corneal curvature). Serious complications, including significant vision loss or internal bleeding, are uncommon. Most side effects, if they arise, can be effectively managed with medications and close follow-up care.
Our Cornea Specialists follow rigorous sterile surgical protocols and rely on advanced pre-operative imaging to plan each procedure precisely. All donor tissue is provided through accredited eye banks that subject each graft to strict screening for infectious disease and tissue quality. Regular post-operative examinations allow early detection and prompt treatment of any developing complications. Your commitment to the prescribed care plan plays an equally important role in achieving a safe and successful outcome.
Recovery and Long-Term Care
Healing after this combined procedure is gradual. Most patients resume light daily activities within a few weeks, while full visual stabilization and corneal integration can take a year or more. A structured aftercare plan is essential for protecting the new graft and supporting the best possible vision.
In the early recovery period, your eye may feel scratchy or watery, and vision will likely be blurry and variable. It is important to avoid rubbing or applying any pressure to the eye and to use all prescribed drops exactly as directed. Contact your Cornea Specialist promptly if you experience sudden sharp pain, increased redness, or an abrupt change in vision, as these can be early signs of complications that respond best to rapid treatment.
Following these steps consistently throughout your recovery will help protect the graft and reduce the risk of complications.
- Use all prescribed antibiotic and anti-inflammatory drops on the schedule provided, without skipping doses.
- Attend every scheduled follow-up appointment so your surgeon can monitor the graft and assess sutures.
- Wear UV-protective sunglasses outdoors to shield your healing cornea from sunlight and wind.
- Avoid swimming, hot tubs, and exposure to dusty or dirty environments for at least four weeks.
- Refrain from contact sports and strenuous physical activity until your Cornea Specialist gives clearance.
The sutures used to secure the donor graft are not all removed at once. Your surgeon will selectively remove individual sutures over a period of months to up to a year or more, adjusting the corneal curvature and managing astigmatism as the eye heals. Ongoing monitoring appointments are important for detecting any late complications, including delayed rejection, which can occur even years after a successful transplant.
Significant visual improvement can continue for a year or longer as the graft matures and integrates fully. Many patients will need corrective lenses once the cornea has stabilized. If irregular astigmatism remains, specialty contact lenses, particularly scleral or rigid gas-permeable (RGP) lenses, can be fitted to achieve the sharpest possible vision. Our optometry team has extensive experience fitting specialty lenses for post-transplant patients and works closely with our Cornea Specialists to support your visual recovery at every stage.
Frequently Asked Questions
These questions address practical aspects of the combined CXL and PKP procedure that are not fully covered elsewhere on this page, including timing, coordination, and what to monitor during recovery.
Yes. In some cases, cross-linking is performed as a secondary procedure after a PKP transplant has already healed, particularly if the graft shows signs of progressive shape changes or instability. Your Cornea Specialist will assess whether the graft has sufficient thickness and stability to safely undergo CXL and will time the procedure accordingly.
All donor corneas used at our practice come from eye banks accredited by national standards. Each graft is rigorously tested for infectious diseases and evaluated for tissue quality and optical clarity before it is approved for use. Your surgeon reviews the tissue characteristics to confirm the graft is appropriate for your case.
Many patients achieve improved functional vision after surgery but retain some degree of irregular astigmatism that glasses cannot fully correct. In these cases, scleral or RGP contact lenses are often recommended to vault over the irregular surface and provide a smooth optical surface. Our optometry team is experienced in fitting these specialty lenses for post-transplant patients and collaborates closely with our Cornea Specialists throughout your rehabilitation.
Graft rejection is a recognized risk after corneal transplantation and can occur even months or years after a successful surgery. Warning signs include a sudden increase in redness, light sensitivity, pain, or a noticeable decrease in vision. These symptoms should prompt an urgent call or visit to your Cornea Specialist, as early treatment with anti-rejection eye drops can often reverse the episode when caught quickly. Do not wait to see if symptoms resolve on their own.
PKP is generally covered by most insurance plans when it is documented as medically necessary. Coverage for the cross-linking component can vary by insurer and by the specific diagnosis involved. Our team will work with you to document the medical necessity of your treatment and help you understand your coverage options and any potential out-of-pocket costs before your procedure is scheduled.
Chronic dry eye can slow surface healing, increase post-operative discomfort, and affect how well the graft integrates with the surrounding tissue. If dry eye is present, our team will assess and optimize its management before surgery, often with lubricating drops, lid hygiene protocols, or other targeted treatments. Addressing dry eye proactively both before and after your procedure contributes meaningfully to a smoother recovery and a healthier long-term outcome.
Care for Complex Corneal Disease at Rhode Island Eye Institute
Our Cornea Specialists at Rhode Island Eye Institute bring fellowship-trained expertise, Brown University academic affiliations, and decades of combined surgical experience to the care of patients facing the most challenging corneal conditions in Rhode Island and southeastern Massachusetts. From your first consultation through the full course of your visual rehabilitation, our integrated team of surgeons and optometrists is with you at every step, focused on preserving your vision and your quality of life.